NeuroSense Therapeutics Ltd. (NRSN)
NRSN Stock Price Chart
Explore NeuroSense Therapeutics Ltd. interactive price chart. Choose custom timeframes to analyze NRSN price movements and trends.
NRSN Company Profile
Discover essential business fundamentals and corporate details for NeuroSense Therapeutics Ltd. (NRSN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Dec 2021
Employees
17.00
Website
https://www.neurosense-tx.comCEO
Alon Ben-Noon
Description
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
NRSN Financial Timeline
Browse a chronological timeline of NeuroSense Therapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.20, while revenue estimate is $514.10k.
Earnings released on 30 Jun 2026
Earnings released on 6 Apr 2026
EPS came in at -$0.24 falling short of the estimated -$0.07 by -231.92%.
Earnings released on 17 Dec 2025
EPS came in at -$0.11 .
Earnings released on 28 May 2025
EPS came in at -$0.11 falling short of the estimated -$0.10 by -4.80%.
Earnings released on 7 Apr 2025
EPS came in at -$0.06 surpassing the estimated -$0.11 by +45.45%.
Earnings released on 18 Dec 2024
EPS came in at -$0.11 surpassing the estimated -$0.16 by +31.25%.
Earnings released on 30 Sept 2024
EPS came in at -$0.02 surpassing the estimated -$0.20 by +90.00%.
Earnings released on 5 Apr 2024
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%.
Earnings released on 22 Mar 2024
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%.
Earnings released on 28 Nov 2023
EPS came in at $0.10 surpassing the estimated -$0.24 by +141.67%.
Earnings released on 16 Aug 2023
EPS came in at -$0.44 falling short of the estimated -$0.28 by -57.14%.
Earnings released on 1 Jun 2023
EPS came in at -$0.33 falling short of the estimated -$0.29 by -13.79%.
Earnings released on 22 Mar 2023
EPS came in at -$0.27 surpassing the estimated -$0.28 by +3.57%.
Earnings released on 1 Dec 2022
EPS came in at -$0.25 surpassing the estimated -$0.28 by +10.71%.
Earnings released on 31 Aug 2022
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%.
Earnings released on 31 May 2022
EPS came in at -$0.24 falling short of the estimated -$0.18 by -33.33%.
Earnings released on 14 Apr 2022
EPS came in at -$0.24 falling short of the estimated -$0.16 by -50.00%.
Earnings released on 10 Dec 2021
EPS came in at -$0.08 .
Earnings released on 21 Sept 2021
EPS came in at -$0.19 .
NRSN Stock Performance
Access detailed NRSN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
